Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2021-10-04 Regulatory Filings
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1912 characters) and contains the header 'RNS Number : 9417N'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and mentions that RNS is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This structure—a brief, time-sensitive announcement distributed via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, it should be classified as a Regulatory Filing (RNS).
2021-10-04 English
Director/PDMR Shareholding - Replacement
Director's Dealing Classification · 1% confidence The document is an official notification released via RNS (RNS Number: 0484M) concerning a transaction in the company's shares by a Director/PDMR (Dr Alastair Riddell). The content explicitly details the purchase of Ordinary Shares by an insider, including price, volume, and date. This directly matches the definition of 'Director's Dealing' (Code: DIRS). Although it is an RNS release, the specific content is highly indicative of DIRS, which takes precedence over the general RNS fallback.
2021-09-16 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS, the news service of the London Stock Exchange'. The content details a 'Director/PDMR Shareholding' transaction, specifically a purchase of shares by the Chairman, Dr Alastair Riddell. This type of insider transaction disclosure is a specific regulatory filing requirement. While it is a regulatory announcement, the most specific category provided that covers insider trading/director dealings is 'Director's Dealing' (DIRS). It is not a general regulatory filing (RNS) because a more specific category exists, and it is not a general announcement (RPA) because it contains the detailed transaction data, not just an announcement that a report is available.
2021-09-16 English
Licensing agreement with Oxilio for NXP001
M&A Activity Classification · 1% confidence The document begins with 'RNS Number : 4839L' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. This strongly indicates a regulatory news service announcement. The content details a 'Worldwide licensing agreement' between Nuformix PLC and Oxilio Ltd regarding a drug candidate (NXP001). This type of corporate transaction announcement, disseminated via the official regulatory news channel (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER), a management change (MANG), or a director dealing (DIRS). Given the source and nature (a formal announcement of a business deal), RNS is the most appropriate classification.
2021-09-13 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Results of Annual General Meeting' and provides a detailed table showing the voting results for various resolutions proposed at the AGM, including receiving the annual report, approving remuneration policy, and re-appointing directors and auditors. This content directly corresponds to the declaration of voting results from a general meeting. Therefore, the classification is DVA (Declaration of Voting Results & Voting Rights Announcements). Although it mentions the 'annual report and accounts' (Resolution 1), the primary purpose and content of this specific filing is the outcome of the shareholder vote, not the full report itself.
2021-08-24 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3517 characters) with the title "Posting of Annual Report and Notice of AGM". It explicitly states that the Annual Report and Accounts and the Notice of AGM "will be posted to shareholders later today and will be available in full to download... shortly." This fits the definition of a Report Publication Announcement (RPA) as per the 'MENU VS MEAL' rule, as it announces the availability of other documents (10-K and AGM-R) rather than being the full report itself. The presence of the RNS Number and the LSE context further confirms it is a regulatory announcement.
2021-07-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.